Measurement of skeletal muscle glucose utilization by dynamic f-fdg pet without arterial blood sampling

Nuclear Medicine Communications

Volumn 26, Issue 1, 2005, Pages 31-37

  Yokoyama, Ikuo ^a   Inoue, Yusuke ^a   Moritan, Toshiyuki ^a   Ohtomo, Kuni ^a   Nagai, Ryozo ^a  

^a Sanno Hospital   (United States)

Author keywords

FDG; Glucose metabolism; Insulin resistance; PET; Skeletal muscle

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; BLOOD VESSEL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE UTILIZATION; HEART MUSCLE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LEG MUSCLE; MALE; MEASUREMENT; POSITRON EMISSION TOMOGRAPHY; SKELETAL MUSCLE; THORAX RADIOGRAPHY; VENOUS BLOOD;

ADULT; AGED; ARTERIES; DIABETES MELLITUS; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HIP; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUSCLE, SKELETAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THORAX;

EID: 13244298232     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200501000-00006     Document Type: Article

References (27)

1. Kelley DE, Price JC, Cobelli C. Assessing skeletal muscle glucose metabolism with positron emission tomography. IUBMB Life 2001; 52:279-284.
2. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37:1595-1607.
3. DeFronzo RA. Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web. J Cardiovasc Pharmacol 1992; 20(suppl 11):S1-S16.
4. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334:952-957.
5. Voipio-Pulkki LM, Nuutila P, Knuuti MJ, Ruotsalainen U, Haaparanta M, Teras M, et al. Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography. J Nucl Med 1993; 34:2064-2067.
6. Nuutila P, Knuuti J, Ruotsalainen U, Koivisto VA, Eronen E, Teras M, et al. Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes. Am J Physiol 1993; 264:E756-E762.
7. Nuutila P, Knuuti MJ, Maki M, Laine H, Ruotsalainen U, Teras M, et al. Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes 1995; 44:31-36.
8. Nuutila P, Maki M, Laine H, Knuuti MJ, Ruotsalainen U, Luotolahti M, et al. Insulin action on heart and skeletal muscle glucose uptake in essential hypertension. J Clin Invest 1995; 96:1003-1009.
9. Yokoyama I, Ohtake T, Momomura S, Yonekura K, Yamada N, Nishikawa J, et al. Organ-specific insulin resistance in patients with noninsulin-dependent diabetes mellitus and hypertension. J Nucl Med 1998; 39:884-889.
10. Utriainen T, Takala T, Luotolahti M, Ronnemaa T, Laine H, Ruotsalainen U, et al. Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM. Diabetologia 1998; 41:555-559.
11. Yokoyama I, Ohtake T, Momomura S, Yonekura K, Kobayakawa N, Aoyagi T, et al. Insulin action on heart and skeletal muscle FDG uptake in patients with hypertriglyceridemia. J Nucl Med 1999; 40:1116-1121.
12. Nuutila P, Koivisto VA, Knuuti J, Ruotsalainen U, Teras M, Haaparanta M, et al. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest 1992; 89:1767-1774.
13. Paternostro G, Camici PG, Lammerstma AA, Marinho N, Baliga RR, Kooner JS, et al. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J Clin Invest 1996; 98:2094-2099.
14. Yokoyama I, Yonekura K, Ohtake T, Kawamura H, Matsumoto A, Inoue Y, et al. Role of insulin resistance in heart and skeletal muscle F-18 fluorodeoxyglucose uptake in patients with non-insulin-dependent diabetes mellitus. J Nucl Cardiol 2000; 7:242-248.
15. Iozzo P, Chareonthaitawee P, Dutka D, Betteridge DJ, Ferrannini E, Camici PG. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes. 2002; 51:3020-3024.
16. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983; 3:1-7.
17. Gambhir SS, Schwaiger M, Huang SC, Krivokapich J, Schelbert HR, Nienaber CA, et al. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med 1989; 30:359-366.
18. Ohtake T, Kosaka N, Watanabe T, Yokoyama I, Moritan T, Masuo M, et al. Noninvasive method to obtain input function for measuring tissue glucose utilization of thoracic and abdominal organs. J Nucl Med 1991; 32:1432-1438.
19. 18F-FDG PET scans. J Nucl Med 2001; 42:1622-1629.
20. Yokoyama I, Yonekura K, Moritan T, Tateno M, Momose T, Ohtomo K, et al. Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients. J Nucl Med 2001; 42:1005-1010.
21. 18F-FDG PET. J Nucl Med 2003; 44:1592-1598.
22. Ehrenkaufer RE, Potocki JF, Jewett DM. Simple synthesis of F-18-labeled 2-fluoro-2-deoxy-D-glucose: concise communication. J Nucl Med 1984; 25:333-337.
23. 18F]fluorodeoxyglucose in human skeletal muscle. J Nucl Med 1999; 40:1798-1804.
24. 18F]fluorodeoxyglucose in skeletal muscles of obese and nonobese humans. Am J Physiol Endocrinol Metab 2000; 279:E1122-E1130.
25. Williams KV, Price JC, Kelley DE. Interactions of impaired glucose transport and phosphorylation in skeletal muscle insulin resistance: a dose-response assessment using positron emission tomography. Diabetes 2001; 50:2069-2079.
26. Lackner R, Challiss RA, West D, Newsholme EA. A problem in the radiochemical assay of glucose-6-phosphatase in muscle. Biochem J 1984; 218:649-651.
27. van der Weerdt AP, Klein LJ, Visser CA, Visser FC, Lammertsma AA. Use of arterialised venous instead of arterial blood for measurement of myocardial glucose metabolism during euglycaemic-hyperinsulinaemic clamping. Eur J Nucl Med Mol Imaging 2002; 29:663-669.